This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Satsuma Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Salvador Rico: Innovator in Headache Treatment
Introduction
Salvador Rico is a notable inventor based in Berkeley, CA, who has made significant contributions to the field of headache treatment. His innovative work focuses on the development of formulations that utilize dihydroergotamine (DHE) for effective headache relief.
Latest Patents
Rico holds a patent for "Intranasal DHE for the treatment of headache." This patent presents powder formulations comprising dihydroergotamine, or a pharmaceutically acceptable salt thereof. The methods described in the patent involve intranasally administering these powder formulations, which can be used for treating headaches, including the rapid onset treatment of migraines, both with and without aura.
Career Highlights
Salvador Rico is currently associated with Satsuma Pharmaceuticals, Inc., where he continues to advance his research and development efforts in headache treatments. His work is pivotal in providing new therapeutic options for individuals suffering from migraines.
Collaborations
Rico collaborates with esteemed colleagues such as Nikhilesh N Singh and John Kollins, contributing to a dynamic research environment focused on innovative healthcare solutions.
Conclusion
Salvador Rico's contributions to headache treatment through his patent on intranasal DHE formulations exemplify his commitment to improving patient care. His work continues to pave the way for advancements in the treatment of migraines and other headache disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile